Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
65 studies found for:    exendin
Show Display Options
Rank Status Study
1 Completed Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
Condition: Hyperglycemia
Interventions: Drug: GLP-1 control;   Drug: GLP-1 and Exendin(9-39) 300;   Drug: saline control;   Drug: GLP-1 and Exendin(9-39) 600;   Drug: GLP-1 and Exendin(9-39) 900;   Drug: GLP-1 and Exendin(9-39) 1200
2 Completed Effects of Exendin(9-39) on Gastroduodenal Motility
Conditions: Digestive Physiology;   Gastrointestinal Motility;   Gastrointestinal Hormones;   Glucagon-Like Peptide 1;   Exendin (9-39)
Interventions: Drug: exendin(9-39)amide;   Drug: atropine
3 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Intervention: Drug: Exendin-(9-39)
4 Completed Dose-response Study of Exendin-9,39 on Glucose Metabolism
Condition: Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
Interventions: Drug: saline infusion;   Drug: GLP-1-9,36 infusion;   Drug: Exendin-9,39 at low dose;   Drug: Exendin-9,39 at high dose
5 Completed Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
Condition: Appetite and General Nutritional Disorders
Interventions: Dietary Supplement: Saline;   Drug: Exendin 9-39;   Drug: Exendin(9-39) plus ID nutrient
6 Recruiting New Imaging Procedure for the Localisation of Insulinoma and Transplanted Islet Cells
Conditions: Endogenous Hyperinsulinaemic Hypoglycaemia;   Transplanted Islet Cells
Intervention: Other: Ga -exendin PET/CT, In- exendin SPECT/CT, MRI
7 Not yet recruiting A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake
Conditions: Obesity;   Diabetes;   Roux-en-Y Gastric Bypass
Intervention: Drug: Exendin-9,39
8 Recruiting Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
Condition: Congenital Hyperinsulinism
Interventions: Drug: Exendin-(9-39);   Drug: placebo
9 Active, not recruiting Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia
Condition: Postprandial Hypoglycemia
Interventions: Drug: exendin-(9-39);   Other: placebo normal saline
10 Recruiting A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Intervention: Drug: Exendin-4 (Exenatide)
11 Active, not recruiting Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Intervention: Drug: exendin-(9-39)
12 Unknown  Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
Conditions: Hyperinsulinism;   Hypoglycemia;   Insulinoma
Intervention: Other: 111In-exendin-4 imaging
13 Completed Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo tablet;   Drug: Sitagliptin tablet;   Drug: Saline infusion;   Drug: Exendin(9-39) infusion
14 Recruiting Ghrelin Effect on Beta Cell Function in Health and Disease
Condition: Diabetes
Interventions: Drug: Exendin (9-39);   Drug: acyl ghrelin;   Drug: saline
15 Not yet recruiting Effect of GLP-1 on Postprandial Lipid Metabolism
Condition: Heart Disease
Interventions: Drug: Exendin-9;   Drug: GLP-1;   Other: saline
16 Completed The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exendin 9, 39;   Drug: Placebo
17 Unknown  Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Condition: Parkinson's Disease
Intervention: Drug: Exenatide
18 Recruiting GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Condition: Healthy
Interventions: Other: 1,5 nmol/kg,GLP-1 sc injection;   Other: 1,5 nmol/kg GLP-1 9-36amide, sc injection;   Other: Exendin-4 ;10 ug,sc injection;   Other: saline
19 Completed GLP-1 - Regulatory Mechanism of Postprandial Glycemia
Conditions: Healthy Subjects;   Gastric Emptying
Interventions: Drug: Saline;   Drug: Exendin(9-39)amide
20 Recruiting A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: HM11260C;   Drug: Placebo;   Drug: Victoza

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years